review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033622899 |
P356 | DOI | 10.1007/BF02780523 |
P698 | PubMed publication ID | 10962525 |
P2093 | author name string | Cariello A | |
Dazzi C | |||
De Giorgi U | |||
Fiorentini G | |||
Giovanis P | |||
Guglielminetti D | |||
Latino W | |||
Leoni M | |||
Marangolo M | |||
Poddie DB | |||
Turci D | |||
P2860 | cites work | The effects on toxicity of circadian patterning of continuous hepatic artery infusion | Q28316522 |
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial | Q34683968 | ||
The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR | Q36712357 | ||
Improved regional selectivity of hepatic arterial mitomycin by starch microspheres | Q38583379 | ||
Antibody-guided irradiation of hepatic metastases using intrahepatically administered radiolabelled anti-CEA antibodies with simultaneous and reversible hepatic blood flow stasis using biodegradable starch microspheres. | Q38594033 | ||
Treatment of carcinoid liver metastases by hepatic-artery embolisation | Q39472675 | ||
Combined hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study | Q41215798 | ||
Hepatic artery ligation with and without portal infusion of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group). | Q42070955 | ||
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial | Q43909975 | ||
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history | Q43990247 | ||
Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study | Q44021143 | ||
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study | Q44664927 | ||
Concomitant radiation therapy and constant infusion FUdR for unresectable hepatic metastases | Q45279885 | ||
Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer | Q45956975 | ||
Antiblastic hypoxic stop-flow perfusion in the treatment of liver metastasis: preliminary results | Q50159045 | ||
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. | Q52432978 | ||
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. | Q52693985 | ||
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer | Q67483147 | ||
Glass yttrium-90 microspheres for patients with colorectal liver metastases | Q67584387 | ||
Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer | Q67993624 | ||
Experimental and clinical observations on hepatic cryosurgery for colorectal metastases | Q68032795 | ||
Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results | Q68189530 | ||
[Hepatic arterial infusion chemotherapy using implantable reservoir in colorectal liver metastasis] | Q68351432 | ||
Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma | Q68426239 | ||
Liver metastases: results of percutaneous ethanol injection in 14 patients | Q70147984 | ||
Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy | Q70200033 | ||
Chemonecrosis for localized dynamic destruction of hepatic metastases of colonic cancer. A new approach | Q70532774 | ||
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer | Q70543544 | ||
Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial | Q70586520 | ||
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer | Q71039774 | ||
Hepatic artery ligation for liver metastasis in colorectal carcinoma | Q71256283 | ||
Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer | Q71380388 | ||
Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature | Q71659207 | ||
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases | Q71692735 | ||
Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients | Q71955982 | ||
Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases | Q71955986 | ||
The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy | Q72334006 | ||
Intra-arterial 131-I-macroaggregated albumin to define intrahepatic tumors: a possible method of quantitating tumor response to therapy | Q72390211 | ||
Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up | Q72729791 | ||
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update | Q72785472 | ||
Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres | Q72787547 | ||
Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol | Q72912879 | ||
Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes | Q73843525 | ||
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver | Q74784129 | ||
Management of hepatic metastases from colorectal cancer: systemic chemotherapy | Q77621017 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
chemotherapy | Q974135 | ||
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 163-173 | |
P577 | publication date | 2000-08-01 | |
P1433 | published in | Medical Oncology | Q2152666 |
P1476 | title | Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments | |
P478 | volume | 17 |